Literature DB >> 28785121

Bunching at the kink: implications for spending responses to health insurance contracts.

Liran Einav1, Amy Finkelstein2, Paul Schrimpf3.   

Abstract

A large literature in empirical public finance relies on "bunching" to identify a behavioral response to non-linear incentives and to translate this response into an economic object to be used counterfactually. We conduct this type of analysis in the context of prescription drug insurance for the elderly in Medicare Part D, where a kink in the individual's budget set generates substantial bunching in annual drug expenditure around the famous "donut hole". We show that different alternative economic models can match the basic bunching pattern, but have very different quantitative implications for the counterfactual spending response to alternative insurance contracts. These findings illustrate the importance of modeling choices in mapping a compelling reduced form pattern into an economic object of interest.

Entities:  

Keywords:  Bunching; Health care; Health insurance; Medicare

Year:  2016        PMID: 28785121      PMCID: PMC5544036          DOI: 10.1016/j.jpubeco.2016.11.011

Source DB:  PubMed          Journal:  J Public Econ        ISSN: 0047-2727


  6 in total

1.  Adjustment Costs, Firm Responses, and Micro vs. Macro Labor Supply Elasticities: Evidence from Danish Tax Records.

Authors:  Raj Chetty; John N Friedman; Tore Olsen; Luigi Pistaferri
Journal:  Q J Econ       Date:  2011-05-01

2.  The RAND Health Insurance Experiment, three decades later.

Authors:  Aviva Aron-Dine; Liran Einav; Amy Finkelstein
Journal:  J Econ Perspect       Date:  2013

3.  Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets.

Authors:  Jason Abaluck; Jonathan Gruber; Ashley Swanson
Journal:  J Public Econ       Date:  2018-06-14

4.  Selection on Moral Hazard in Health Insurance.

Authors:  Liran Einav; Amy Finkelstein; Stephen Ryan; Paul Schrimpf; Mark R Cullen
Journal:  Am Econ Rev       Date:  2013-02

5.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

6.  MORAL HAZARD IN HEALTH INSURANCE: DO DYNAMIC INCENTIVES MATTER?

Authors:  Aviva Aron-Dine; Liran Einav; Amy Finkelstein; Mark Cullen
Journal:  Rev Econ Stat       Date:  2015-10
  6 in total
  2 in total

1.  Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.

Authors:  Liran Einav; Amy Finkelstein; Maria Polyakova
Journal:  Am Econ J Econ Policy       Date:  2018-08

2.  Moral Hazard in Health Insurance: What We Know and How We Know It.

Authors:  Liran Einav; Amy Finkelstein
Journal:  J Eur Econ Assoc       Date:  2018-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.